59932 Federal Register / Vol. 69, No. 193 / Wednesday, October 6, 2004 / Notices 

Dennis Smith, Director, Center for Medicaid 

and State Operations. 

Patricia Smith, Director, Health Plans 

Benefits Group. 

Stewart Streimer, Director, Provider Billing 

Group. 

Brenda Sykes, Deputy Director, Office of 

Operations Management. 

Deborah Taylor, Deputy Director, Office of 

Financial Management. 

Joe Tilghman, Kansas City Regional 

Administrator. 

Alexander Trujillo, Denver Regional 

Administrator. 

Sean Tunis, Director, Office of Clinical 

Standards and Quality. 

John Voorhees, Director, Office of Operations 

Management. 

Gerald Walters, Director, Financial Services 

Group. 

Jacqueline White, Director, Office of Strategic 

Operations and Regulatory Affairs. 

Laurence Wilson, Director, Chronic Care 

Policy Group. 

Charlotte Yeh, Boston Regional 

Administrator.

Dated: September 20, 2004. 

Leslie V. Norwalk, 

Deputy Administrator, Centers for Medicare 

& Medicaid Services.

[FR Doc. 04–22418 Filed 10–1–04; 11:46 am] 

BILLING CODE 4120–01–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES

Food and Drug Administration

Request for Nominations for Voting 

Members of a Public Advisory 

Committee and Subcommittees

AGENCY: Food and Drug Administration, 

HHS.

ACTION: Notice.

The Food and Drug Administration 

(FDA) is requesting nominations for 

voting members to serve on the Food 

Advisory Committee (the Parent 

Committee) and certain subcommittees 

of the Food Advisory Committee in 

FDA’s Center for Food Safety and 

Applied Nutrition (CFSAN). 

Nominations will be accepted for 

current vacancies and those that will or 

may occur through June 30, 2005.

FDA has special interest in ensuring 

that women, minority groups, and 

individuals with disabilities are 

adequately represented on advisory 

committees and, therefore, encourages 

nominations of qualified candidates 

from these groups.

DATES: Because scheduled vacancies 

occur on various dates throughout the 

year, no cutoff date is established for the 

receipt of nominations. However, when 

possible, nominations should be 

received at least 6 months before the 

date of scheduled vacancies for each 

year, as indicated in this document.

ADDRESSES: Send all nominations and 

curricula vitae to Carolyn Jeletic, Center 

for Food Safety and Applied Nutrition 

(HFS–6), Food and Drug 

Administration, 5100 Paint Branch 

Pkwy., College Park, MD 20740, 301–

436–2397, FAX: 301–436–2633, e-mail: 

Carolyn.Jeletic@cfsan.fda.gov.

SUPPLEMENTARY INFORMATION: FDA is 

requesting nominations of voting 

members for the vacancies listed in 

table 1 of this document.

I. Vacancies

FDA is requesting nominations of 

voting members for vacancies listed as 

follows:

TABLE 1.

Advisory Committee, Subcommittees, and Expertise Needed to Fill Vacancies 

Number of

Vacancies

Approximate Date

Members Are 

Needed

Food Advisory Committee (Parent Committee): Physical sciences; biological and life sciences; epidemiology; risk assessment; toxicology; nutrition; food science, technology, or engineering; medical and 

public health sciences; and other relevant scientific and technical disciplines 6 June 30, 2005.

Additives and Ingredients Subcommittee of the Food Advisory Committee: Toxicology and food chemistry 7 June 30, 2005.

Contaminants and Natural Toxicants Subcommittee of the Food Advisory Committee: Food science, 

food chemistry, food microbiology, toxicology, and risk analysis 4 June 30, 2005.

Dietary Supplements Subcommittee of the Food Advisory Committee: Biological sciences and medical, 

hospital, dental, and public health 5 June 30, 2005.

Infant Formula Subcommittee of the Food Advisory Committee: Biological sciences and medical, hospital, dental, and public health 3 June 30, 2005.

Food Biotechnology Subcommittee of the Food Advisory Committee: Food biotechnology 5 June 30, 2005.

Nutrition Subcommittee of the Food Advisory Committee: Biological sciences and medical, hospital, 

dental, and public health 1 June 30, 2005.

II. Functions

The Parent Committee provides 

advice primarily to the Director of 

CFSAN, and as needed, to the 

Commissioner of Food and Drugs, and 

other appropriate officials, on emerging 

food safety, food science, nutrition, and 

other food-related issues that FDA 

considers of primary importance for its 

food and cosmetics program. The Parent 

Committee may be charged with 

reviewing and evaluating available data 

and making recommendations on 

matters such as those relating to the 

following topics: (1) Broad scientific 

and technical food or cosmetic related 

issues, (2) the safety of new foods and 

food ingredients, (3) labeling of foods 

and cosmetics, (4) nutrient needs and 

nutritional adequacy, and (5) safe 

exposure limits for food contaminants. 

The Parent Committee also may be 

asked to provide advice and make 

recommendations on ways of 

communicating to the public the 

potential risks associated with these 

issues and on approaches that might be 

considered for addressing the issues.

III. Qualifications

Persons nominated for membership 

on the Parent Committee and 

subcommittees shall be knowledgeable 

in the fields of physical sciences, 

Federal Register / Vol. 69, No. 193 / Wednesday, October 6, 2004 / Notices 59933

biological and life sciences, food 

science, risk assessment, and other 

relevant scientific and technical 

disciplines. The agency is particularly 

interested in considering candidates 

with a comprehensive background in 

food technology, molecular biology, 

genetics, biotechnology, and a variety of 

medical specialties, as many issues 

brought before the Committee involve 

medical or epidemiological impact on 

nutrients, additives, contaminants, or 

other constituents of the diet, such as 

dietary supplements. The term of office 

is for up to 4 years, depending on the 

appointment date.

IV. Nomination Procedures

Any interested person may nominate 

one or more qualified persons for 

membership on the Parent Committee or 

one or more of the subcommittees. Selfnominations are also accepted. 

Nominations shall include the name of 

the committee or subcommittee, a 

complete curriculum vitae of each 

nominee, current business address and 

telephone number, and shall state that 

the nominee is aware of the nomination, 

is willing to serve as a member of the 

Parent Committee or subcommittee 

(name of committee/subcommittee(s) 

must be specified), and appears to have 

no conflict of interest that would 

preclude membership. FDA will ask the 

potential candidates to provide detailed 

information concerning such matters as 

financial holdings, employment, and 

research grants and/or contracts to 

permit evaluation of possible sources of 

conflicts of interest.

This notice is issued under the 

Federal Advisory Committee Act (5 

U.S.C. app. 2) and 21 CFR part 14, 

relating to advisory committees.

Dated: October 1, 2004.

Sheila Dearybury Walcoff,

Associate Commissioner for External 

Relations.

[FR Doc. 04–22498 Filed 10–5–04; 8:45 am]

BILLING CODE 4160–01–S

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES

Food and Drug Administration

Memorandum of Understanding 

Between the State of Iowa, Department 

of Public Health, Bureau of 

Radiological Health and the Food and 

Drug Administration, Center for 

Devices and Radiological Health

AGENCY: Food and Drug Administration, 

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug 

Administration (FDA) is providing 

notice of a memorandum of 

understanding (MOU) between the State 

of Iowa, through the Iowa Department of 

Public Health, Bureau of Radiological 

Health and the Food and Drug 

Administration, Center for Devices and 

Radiological Health, to continue to 

conduct a State as certifiers program in 

Iowa under the Mammography Quality 

Standards Act.

DATES: The agreement became effective 

August 18, 2004.

FOR FURTHER INFORMATION CONTACT:

Joanne Choy, Division of Mammography 

Quality and Radiation Programs (HFZ–

240), Food and Drug Administration, 

1350 Piccard Dr., Rockville, MD 20850, 

301–827–2903, or e-mail: 

jkc@cdrh.fda.gov.

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 20.108(c), 

which states that all written agreements 

and MOUs between FDA and others 

shall be published in the Federal 

Register, the agency is publishing notice 

of this MOU.

Dated: September 30, 2004.

Jeffrey Shuren,

Assistant Commissioner for Policy.

BILLING CODE 4160–01–S